PUK12 ANALYSIS OF COST AND CONSEQUENCES RELATED TO THE PERSISTENCE OF MIRABEGRON AND ANTIMUSCARINIC TREATMENTS AND THEIR IMPACT ON QUALITY OF LIFE IN PATIENTS AGED ≥ 65 YEARS WITH OVERACTIVE BLADDER IN SPAIN
Abstract
Authors
S. Arlandis Guzmán M. jimenez-Cidre D. Rubio-Rodriguez C. Rubio Terrés M. Landeira N. Blanco